These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7441495)

  • 21. Effect of liver function on the metabolism of prednisone and prednisolone in humans.
    Renner E; Horber FF; Jost G; Frey BM; Frey FJ
    Gastroenterology; 1986 Apr; 90(4):819-28. PubMed ID: 3512355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prednisone and prednisolone interconversion in the rabbit utilizing unbound concentrations.
    Hammarlund-Udenaes M; Benet LZ
    Biopharm Drug Dispos; 1991; 12(6):467-77. PubMed ID: 1932610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans.
    Mahmood I
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1439-46. PubMed ID: 11185664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data.
    Bannwarth B; Schaeverbeke T; Péhourcq F; Vernhes JP; D'Yvoire MB; Dehais J
    Rev Rhum Engl Ed; 1997 May; 64(5):301-4. PubMed ID: 9190003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Jun; 30(3):224-33. PubMed ID: 17472654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.
    Iwatsubo T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Representation and quantitation of the binding interaction between prednisone, prednisolone and corticosteroid binding globulin.
    Unadkat JD; Rowland M
    J Pharm Pharmacol; 1984 Sep; 36(9):582-5. PubMed ID: 6149280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats.
    Han YH; Kato Y; Sugiyama Y
    J Pharmacol Exp Ther; 1999 Oct; 291(1):204-12. PubMed ID: 10490906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring prednisone and prednisolone.
    Jusko WJ; Rose JQ
    Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxycholate effects on plasma solute clearance by gut perfusion in dog.
    Kwon ED; Schedl HP; Donovan JF
    J Surg Res; 1994 Nov; 57(5):549-55. PubMed ID: 7967592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of prednisone and prednisolone.
    Frey BM; Frey FJ
    Clin Pharmacokinet; 1990 Aug; 19(2):126-46. PubMed ID: 2199128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent protein binding and disposition of prednisolone in rabbits.
    Rocci ML; Jusko WJ
    J Pharm Sci; 1981 Nov; 70(11):1201-4. PubMed ID: 7299663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants.
    Gambertoglio JG; Holford NH; Kapusnik JE; Nishikawa R; Saltiel M; Stanik-Lizak P; Birnbaum JL; Hau T; Amend WJ
    Kidney Int; 1984 Jan; 25(1):119-23. PubMed ID: 6374250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.